Takeda San Francisco, Inc., announced September 21, 2009 that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles S. Craik, PhD, faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy. Craik will be the principal investigator of the project, which will focus on therapeutic antibody discovery and development to an undisclosed target.
